Product Code: GVR-2-68038-510-6
Muscle Stimulator Market Growth & Trends:
The global muscle stimulator market size is anticipated to reach USD 997.3 million by 2030, registering a CAGR of 3.5% over the forecast period, according to a new report by Grand View Research, Inc. The growing prevalence of musculoskeletal disorders and increasing demand for pain management therapies are the key factors driving the growth over the forecast period. Moreover, growing purchasing power, increasing healthcare expenditure, and technological innovations in medical devices are also driving the market growth.
Based on product type, Transcutaneous Electrical Nerve Stimulation (TENS) dominated the global market in 2019. Increasing demand for portable stimulation devices that can be operated at home and rising geriatric population that is prone to develop musculoskeletal disorders are the major factors driving the market growth. On the other hand, Neuromuscular Electrical Stimulation (NES) is estimated to be the fastest-growing segment during the forecast period owing to increasing cases of strokes and spinal cord injuries.
Based on modality, the market is segmented into portable, handheld, and tabletop. Portable stimulator dominated the muscle stimulator space in 2019, owing to the ease of carrying them while traveling and higher purchasing power in the hands of consumers. The segment is also anticipated to grow at the fastest rate of 4.2% during the forecast period. Key players launching innovative portable muscle stimulator devices to sustain market competition is also a major factor driving the segment growth.
Based on applications, the muscle stimulator market is segmented into pain management, neurological disorders, musculoskeletal disorders, and others. The pain management segment dominated the market with a share of 54.5% in 2019 and is anticipated to be the fastest growing segment during the forecast period. Increasing cases of chronic and acute pain and the need for effective pain management therapies among cancer patients are the major factors driving the growth over the forecast period.
Muscle Stimulator Market Report Highlights:
- The global market is anticipated to reach USD 997.3 million by 2030 owing to rising prevalence of musculoskeletal disorders and increasing demand for pain management therapies
- Transcutaneous Electrical Nerve Stimulation (TENS) dominated the muscle stimulator market in 2022, owing to an increase in the demand for portable stimulator
- Portable devices are estimated to witness the fastest growth, as their usage in muscle atrophy, relaxation of muscle spasms, and managing chronic pain is increasing
- In 2022, the pain management application segment dominated the market with a share of 54.5% owing to increasing usage of muscle stimulator in the management of chronic and acute pain
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product Type
- 1.1.2. Modality
- 1.1.3. Application
- 1.1.4. End-Use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Type outlook
- 2.2.2. Modality outlook
- 2.2.3. End-use outlook
- 2.2.4. Application outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Muscle Stimulator Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Muscle Stimulator Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Muscle Stimulator: Product Type Estimates & Trend Analysis
- 4.1. Muscle Stimulator Market: Key Takeaways
- 4.2. Muscle Stimulator Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Neuromuscular Electrical Stimulation
- 4.3.1. Neuromuscular Electrical Stimulation market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Functional Electrical Stimulation
- 4.4.1. Functional Electrical Stimulation market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Transcutaneous Electrical Nerve Stimulation
- 4.5.1. Transcutaneous Electrical Nerve Stimulation market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Interferential
- 4.6.1. Interferential market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Burst Mode Alternating Current
- 4.7.1. Burst Mode Alternating Current market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Micro Current Electrical Neuromuscular Stimulator
- 4.8.1. Micro Current Electrical Neuromuscular Stimulator market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.9. Others
- 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Muscle Stimulator: Modality Estimates & Trend Analysis
- 5.1. Muscle Stimulator Market: Key Takeaways
- 5.2. Muscle Stimulator Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Handheld
- 5.3.1. Handheld market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Portable
- 5.4.1. Portable market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Table Top
- 5.5.1. Table Top market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Muscle Stimulator: Application Estimates & Trend Analysis
- 6.1. Muscle Stimulator Market: Key Takeaways
- 6.2. Muscle Stimulator Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Pain Management
- 6.3.1. Pain Management market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Neurological Disorder
- 6.4.1. Hormone delivery market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Musculoskeletal Disorder
- 6.5.1. Pain management market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Muscle Stimulator Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Muscle Stimulator Market by Region: Key Marketplace Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. NeuroMetrix, Inc.
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. OMRON Corporation
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. BioMedical Life Systems, Inc.
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Zynex , Inc.
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. EMS Physio Ltd.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. DJO Global, Inc.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Beurer GmbH.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives